Congress Theaters

Product Theaters

Congress Theaters are turnkey, 30-minute marketing presentations about a company’s products or services. These sessions do not offer CME credit; rather, they give exhibitors the freedom to create a presentation centered on their company’s products.  

Only Congress Industry Supporters who have secured a booth are eligible to apply for a slot for a product theater, subject to availability and adherence to all published guidelines.

Product Theater Schedule

While you’re at Crohn’s & Colitis Congress® 2026, take advantage of any of the following Product Theaters. All Product Theaters will take place in the Congress Theater, located within the Exhibit Hall. 

All times listed are listed in Pacific Time. Times and programming are subject to change. 

Friday, January 23, 2026

Striving for Durable Outcomes in UC: A therapy that helps achieve powerful symptomatic and endoscopic outcomes for adult TNFi-IR patients with moderate to severe ulcerative colitis.
 
Supported by: AbbVie
Time: 9:30 – 10 a.m.
Speaker: Anita Afzali, MD
 
Anita Afzali, MD will be presenting on Rinvoq, a therapy that helps achieve powerful symptomatic and endoscopic outcomes for adult TNFi-IR patients with moderate to severe ulcerative colitis.  Dr. Afzali is an internationally renowned, board-certified gastroenterologist whose focus is inflammatory bowel disease (IBD).
Strive Towards Treatment Goals
 
Supported by: Eli Lilly and Company
Time: 11:30 a.m. – 12 p.m.
Speakers: Doug Nguyen, MD and Jennifer Geremia, PA-C
 
This presentation includes an overview of disease symptoms/burden and the efficacy and safety data from relevant clinical studies. The facilitator will provide clinical insights and be available for a live Q&A session following the presentation.
ELEVATE UC and ENLIGHT UC Trials: Advancing the Understanding of Clinical Trials Data
 
Supported by: Pfizer
Time: 12:15 – 12:45 p.m.
Speaker: Bincy P. Abraham, MD
 
Don’t miss an exciting presentation from an expert about a prescription tablet from Pfizer. Join us for an overview of key efficacy and safety data, steps in getting patients started, and other clinical treatment considerations
The Robust Clinical Data Behind ENTYVIO (vedolizumab)
 
Supported by: Takeda Pharmaceuticals USA Inc.
Time: 1 – 1:30 p.m.
Speaker: Russel Cohen, MD
 
Join us for a discussion of how ENTYVIO works, its robust clinical profile, administration options with IV or the pen, and patient support. Help empower appropriate patients by providing the resources they need at the beginning of their treatment journey.
TREMFYA® for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis and Moderately to Severely Active Crohn’s Disease
 
Supported by: Johnson & Johnson
Time: 3 – 3:30 p.m.
Speakers: Gil Melmed, MD, MS and Melissa Ferrari, PA-C, MPA
 
Join us as we discuss TREMFYA® (guselkumab) as an option for appropriate patients with Crohn’s disease and ulcerative colitis.

Saturday, January 24, 2026

Understanding Zymfentra(infliximab-dyyb)
 
Supported by: Celltrion USA, Inc
Time: 10 – 10:30 a.m.
Speaker: Dr. Christian Stone
 
Please join us for this product theater with Dr. Christian Stone highlighting the key clinical characteristics of Zymfentra(infliximab-dyyb)

Schedule

All Product Theaters take place in the Congress Theater, which is located in the Exhibit Hall.

All times listed are in Pacific Time. Times and programming are subject to change.

Friday, January 23, 2026

7:15 – 7:45 a.m. 

9:30 10 a.m. 

11:30 a.m. – 12 p.m. 

12:15 – 12:45 p.m. 

1 – 1:30 p.m. 

3 – 3:30 p.m. 

Saturday, January 24, 2026

7:15 – 7:45 a.m. 

10 – 10:30 a.m. 

As more information for the Product Theaters become available this page will be updated. Last updated, December 2025. 

We look forward to working with you and ensuring that you have a positive experience sharing your innovations with our attendees.

Interested in learning more or have additional questions, please contact:

CHLOE STEIN
Senior Coordinator, Industry Sales and Operations 
American Gastroenterological Association 

This website uses cookies to provide you with the best experience on our website. If you wish to disable cookies, please do so in your browser settings. Your continued use of our site without disabling your cookies is subject to the cookie policy. Learn More